UK markets closed

OSE Immunotherapeutics SA (0RAD.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
4.6150-0.0900 (-1.91%)
At close: 08:00AM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.78
52-week change 3-3.23%
S&P500 52-week change 321.83%
52-week high 37.3100
52-week low 32.7333
50-day moving average 34.1871
200-day moving average 34.1763

Share statistics

Avg vol (3-month) 32.67k
Avg vol (10-day) 32.08k
Shares outstanding 514.61M
Implied shares outstanding 6N/A
Float 814.6M
% held by insiders 127.66%
% held by institutions 12.13%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,091.02%

Management effectiveness

Return on assets (ttm)-16.53%
Return on equity (ttm)-82.70%

Income statement

Revenue (ttm)2.23M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)-61.50%
Gross profit (ttm)N/A
EBITDA -20.41M
Net income avi to common (ttm)-23M
Diluted EPS (ttm)-0.9300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)18.67M
Total cash per share (mrq)0.91
Total debt (mrq)45.8M
Total debt/equity (mrq)199.35%
Current ratio (mrq)1.62
Book value per share (mrq)1.12

Cash flow statement

Operating cash flow (ttm)-19.76M
Levered free cash flow (ttm)-11.42M